These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 6318895)

  • 1. Chronic naltrexone increases opiate binding in brain and produces supersensitivity to morphine in the locus coeruleus of the rat.
    Bardo MT; Bhatnagar RK; Gebhart GF
    Brain Res; 1983 Dec; 289(1-2):223-34. PubMed ID: 6318895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naltrexone-induced opiate receptor supersensitivity.
    Zukin RS; Sugarman JR; Fitz-Syage ML; Gardner EL; Zukin SR; Gintzler AR
    Brain Res; 1982 Aug; 245(2):285-92. PubMed ID: 6289965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of morphine tolerance and abstinence on the binding of [3H]naltrexone to discrete brain regions and spinal cord of the rat.
    Reddy PL; Veeranna ; Matwyshyn GA; Thorat SN; Bhargava HN
    Gen Pharmacol; 1994 Mar; 25(2):355-61. PubMed ID: 8026736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of naltrexone on the binding of [3H]D-Ala2, MePhe4, Gly-ol5-enkephalin to brain regions and spinal cord and pharmacological responses to morphine in the rat.
    Bhargava HN; Matwyshyn GA; Reddy PL; Veeranna
    Gen Pharmacol; 1993 Nov; 24(6):1351-7. PubMed ID: 8112506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus.
    Duman RS; Tallman JF; Nestler EJ
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1033-9. PubMed ID: 2843624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic treatment with naltrexone enhances morphine-stimulated dopamine neurotransmission: neurochemical and behavioral evidence.
    Bardo MT; Neisewander JL; Ennis RB
    Neuropharmacology; 1988 Nov; 27(11):1103-9. PubMed ID: 2849725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired supersensitivity to morphine following chronic naltrexone treatment in senescent rats.
    Neisewander JL; Nonneman AJ; Rowlett JK; Bardo MT
    Neurobiol Aging; 1994; 15(1):91-7. PubMed ID: 8159267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous development of opioid tolerance and opioid antagonist-induced receptor upregulation.
    Yoburn BC; Sierra V; Lutfy K
    Brain Res; 1990 Oct; 529(1-2):143-8. PubMed ID: 2178026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased analgesic potency of morphine and increased brain opioid binding sites in the rat following chronic naltrexone treatment.
    Yoburn BC; Goodman RR; Cohen AH; Pasternak GW; Inturrisi CE
    Life Sci; 1985 Jun; 36(24):2325-32. PubMed ID: 2989632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemical and functional correlates of naltrexone-induced opiate receptor up-regulation.
    Tempel A; Gardner EL; Zukin RS
    J Pharmacol Exp Ther; 1985 Feb; 232(2):439-44. PubMed ID: 2982011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel action of morphine in the rat locus coeruleus: persistent decrease in adenylate cyclase.
    Beitner DB; Duman RS; Nestler EJ
    Mol Pharmacol; 1989 May; 35(5):559-64. PubMed ID: 2498635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internalization of mu-opioid receptors produced by etorphine in the rat locus coeruleus.
    Van Bockstaele EJ; Commons KG
    Neuroscience; 2001; 108(3):467-77. PubMed ID: 11738260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mu-opioid receptor redistribution in the locus coeruleus upon precipitation of withdrawal in opiate-dependent rats.
    Scavone JL; Van Bockstaele EJ
    Anat Rec (Hoboken); 2009 Mar; 292(3):401-11. PubMed ID: 19248160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment.
    Tao PL; Law PY; Loh HH
    J Pharmacol Exp Ther; 1987 Mar; 240(3):809-16. PubMed ID: 3031275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic opioid antagonist treatment: assessment of receptor upregulation.
    Yoburn BC; Sierra V; Lutfy K
    Eur J Pharmacol; 1989 Nov; 170(3):193-200. PubMed ID: 2559854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonists.
    Valentino RJ; Katz JL; Medzihradsky F; Woods JH
    Life Sci; 1983 Jun; 32(25):2887-96. PubMed ID: 6304445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cold-restraint stress reduces [3H]etorphine binding to rat brain membranes: influence of acute and chronic morphine and naloxone.
    Hnatowich MR; Labella FS; Kiernan K; Glavin GB
    Brain Res; 1986 Aug; 380(1):107-13. PubMed ID: 3019462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locus ceruleus discharge characteristics of morphine-dependent rats: effects of naltrexone.
    Valentino RJ; Wehby RG
    Brain Res; 1989 May; 488(1-2):126-34. PubMed ID: 2743108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related differences in the effect of chronic administration of naloxone on opiate binding in rat brain.
    Bardo MT; Bhatnagar RK; Gebhart GF
    Neuropharmacology; 1983 Apr; 22(4):453-61. PubMed ID: 6304564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of morphine dependence-related enhancement of secretory protein synthesis in the pons-medulla and striatum-septum by naltrexone.
    Retz KC; Steele WJ
    Neuropharmacology; 1983 Feb; 22(2):183-9. PubMed ID: 6300721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.